How many clinical trials are tracked for Chronic Otitis Media?

24 trials are tracked, 0 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Log in / Sign up

Chronic Otitis Media

5 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Chronic Otitis Media

24 trials tracked for Chronic Otitis Media: 6 in phase 3 or 4.

24Trials tracked

6Phase 3 & 4

0Recruiting

0With published results

Phase distribution

Phase 4 4 Phase 3 2 Phase 2 1 Other / NA 17

Phase 4 Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Otitis Media in India Completed
Phase 4 A Pilot Study to Evaluate the Efficacy of Montelukast in the Treatment of Acute Otitis Media (AOM) in Children Completed
Phase 4 Postoperative Effects of Intranasal Fentanyl, IV and IM Morphine in Children Undergoing Myringotomy Completed
Phase 4 Treatment of Clogged Tympanostomy Tubes: An Off-Label Use of Dornase Alfa (Pulmozyme®) Completed
Phase 3 Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes Completed
Phase 3 Dexmedetomidine Versus Fentanyl Following Pressure Equalization Tube Placement Completed

Show 18 more trials

Phase 2 Effect of Simethicone on Eustachian Tube Dysfunction Completed
N/A Optimal Dose of Combination of Rocuronium and Cisatracurium Completed
N/A Evaluation of Moderate to Severe Influenza Outcomes in Children Completed
N/A Cone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose Completed
N/A Anesthetic Effect of Lidocaine/Epinephrine Solution Delivered Via Iontophoresis to External Auditory Apparatus Completed
N/A Effectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media Completed
N/A Hummingbird TTS Ear Tube Delivery Study Completed
N/A inVENT-visIOn Study Completed
N/A Effect of Prevnar 13 on Ear Infections in Children Completed
N/A Singapore Tympanostomy Tube Delivery System Study Completed
N/A inVENT-In-Office Study Completed
N/A Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion Completed
N/A Homeopathic Ear Drops for Otitis Media Study Completed
N/A In-Office Study of the Hummingbird® in Children 6 Months-21 Years Old Completed
N/A Study of the Hummingbird TTS™ Tympanostomy Tube System Completed
N/A Tympanostomy Tube Placement in Children in the Office (Inova Study) Completed
N/A Retrospective Health Care Utilisation and Current Quality of Life in Adults With Chronic Otitis Media Who Had a Middle Ear Surgery Completed
N/A Efficacy of Platelet- and Extracellular Vesicle-rich Plasma in Chronic Postsurgical Temporal Bone Inflammations Completed

Showing the 24 most-cited and recently-updated of 24 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

Questions about Chronic Otitis Media

Do bone conduction hearing devices improve quality of life for adults with chronic otitis media?

Yes, bone conduction hearing devices significantly improve health-related quality of life for adults with chronic otitis media, based on systematic reviews and clinical studies.

Full answer →

How do genetic factors contribute to a child's risk of otitis media?

Genetic factors increase a child's risk of chronic otitis media by altering immune system responses and middle ear function, with specific gene variants on chromosome 19 identified as significant risk markers.

Full answer →